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Abstract
Background: HIV infection and drugs of abuse such as methamphetamine (METH), cocaine, and alcohol use have
been identified as risk factors for triggering inflammation. Acute phase proteins such as C-reactive protein (CRP)
and serum amyloid A (SAA) are the biomarkers of inflammation. Hence, the interactive effect of drugs of abuse with
acute phase proteins in HIV-positive subjects was investigated.
Methods: Plasma samples were utilized from 75 subjects with METH use, cocaine use, alcohol use, and HIV-positive
alone and HIV-positive METH, cocaine, and alcohol users, and age-matched control subjects. The plasma CRP and
SAA levels were measured by ELISA and western blot respectively and the CD4 counts were also measured.
Results: Observed results indicated that the CRP and SAA levels in HIV-positive subjects who are METH, cocaine and
alcohol users were significantly higher when compared with either drugs of abuse or HIV-positive alone. The CD4 counts
were also dramatically reduced in HIV-positive with drugs of abuse subjects compared with only HIV-positive subjects.
Conclusions: These results suggest that, in HIV-positive subjects, drugs of abuse increase the levels of CRP and SAA,
which may impact on the HIV infection and disease progression.
Keywords: Drugs of abuse, HIV, Plasma, C-reactive protein, Serum amyloid A
Background
Inflammatory proteins such as C-reactive protein (CRP)
and serum amyloid A (SAA) are the plasma proteins
known as acute phase proteins that increase during sys-
temic inflammation. These proteins are present in blood
and are abundantly expressed in the liver [1,2]. CRP binds
with highest affinity to phosphocholine residues and
modifies plasma lipoproteins [3], which alters antioxidant
defense mechanism to promote apoptosis [4]. The pro-
duction of SAA mainly induces proinflammatory cyto-
kines such as TNFα, IL-6 and IL-1. SAA seems to be
involved in circulating the main fibril protein of secondary
amyloidosis and is associated with an increased level
of metalloproteinase, collagen synthesis, and increased
extracellular matrix. An increased level of SAA binds
to lipoproteins during inflammation, which is impli-
cated in atherosclerosis and thrombosis [5]. Acute phase
proteins have been associated with immune dysfunction
and subsequently affect inflammatory cytokines [6], psy-
chological and psychiatric illnesses and pathogens includ-
ing HIV infection [2,7,8]. Studies have shown that
Alzheimer’s disease patients with increased chronic in-
flammation have elevated levels of CRP and SAA in
the brain [9,10]. In dementia patients, CRP and SAA
participate in diverse cellular functions including stress,
depression and cognitive neuronal disorders [11,12]. The
acute phase proteins CRP and SAA play a central role in
the molecular mechanisms triggered after immune
dysfunction in the cardiovascular complication and
neuropathogenesis of HIV disease progression [13,14].
Alcohols as well as illicit drugs such as methampheta-
mine (METH) and cocaine are powerful psychostimulants
that are widely abused in the USA. Illicit drug abuse is a
risk factor that plays a significant role in HIV infection
and AIDS disease progression. According to the National
Household Survey on Drug Abuse, in 2010 about 22.6
million Americans (aged 12 or older) were illicit drug
abusers. Approximately 4.8 million Americans age 12 and
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older had abused cocaine in any form and 1.0 million had
abused crack/cocaine at least once in a year. In alcohol
users almost one-half of Americans aged 12 or older
(51.8%) reported being current drinkers, translating to an
estimated 131.3 million people. In 2010, a revised report
from the National Survey on Drug Use and Health esti-
mated 13 million people age 12 or older (4.3% of the
population) have tried METH [15,16]. Studies have shown
that illicit drugs are risk factors for triggering inflamma-
tion and immune functions [17,18]. These drugs also play
an important role in the etiology of viral infection and dis-
ease progression. Previous studies suggested that drug
abuse, crack/cocaine, METH and alcohol are risk factors
for contracting HIV-1 infection and have been shown to
be independently associated with progression to clinical
AIDS [19-21]. Studies have reported that increased in-
flammatory proteins CRP and SAA in HIV-infected
subjects [22,23] contribute to immune suppression and
disease progression [24]. Alcohol users and abusers of
METH and cocaine develop chronic inflammation that
leads to immune dysfunction as well as neuronal im-
pairments. The interactive role for HIV progression
and exacerbation of acute phase proteins CRP and
SAA linkage remains to be studied. The aim of the
present study was to investigate the levels of CRP and
SAA in METH, cocaine and alcohol users and the ef-
fects on their interactive role with HIV infection and
disease progression.
Methods
Patient population
Human subjects were recruited from collaborating phy-
sicians and community agencies, as well as by participant
referral. After eligibility was confirmed, informed consent
was obtained. Participants provided medical documenta-
tion to confirm HIV and hepatitis B and C status. For
HIV-positive individuals, medical documentation con-
firmed CD4 and viral loads. Individuals younger than
18 years old and with hepatitis B and/or hepatitis C infec-
tion were deemed ineligible. Self-report data were col-
lected concerning drug use history, and participant’s blood
specimens were collected by a registered nurse. All re-
searchers coming into contact with human subjects had
obtained the required collaborative Institutional Review
Board training initiative. The identity of participants was
concealed to maintain participant confidentiality.
Immunoassay of C-reactive protein and serum amyloid A
in plasma
Blood was collected from HIV-infected patients and sub-
stance abusers 24 to 72 hours after the last use of METH,
cocaine, alcohol and marijuana. The blood samples were
centrifuged after collection and residual plasma specimens
were stored at −80°C. CRP was measured in plasma by a
commercial immunoassay kit (Immunoassay Kit #MBS
564038; MBiosource, San Diego, CA, USA). The commer-
cial kit uses a mAb raised against full-length human CRP
to detect and quantify the level of total protein. The SAA
was measured in plasma by another commercial immuno-
assay kit (Immunoassay Kit # ST1056; Calbiochem, San
Diego, CA, USA). This commercial kit uses a mouse mAb
raised against full-length human SAA to detect and quan-
tify the level of total protein.
Western blot analysis of plasma C-reactive protein and
serum amyloid A
To assess the randomly selected plasma CRP and SAA
protein levels from either METH, cocaine, and alcohol
users, HIV-positive subjects alone or HIV-positive with
METH, cocaine and alcohol users, equal amounts of
plasma proteins were resolved on a 4 to 15% gradient
SDS-PAGE, transferred to a nitrocellulose membrane
and incubated with CRP antibodies (Biolegent, San
Diego, CA, USA) and SAA antibodies (Calbiochem) and
their respective secondary antibodies. Immunoreactive
bands were visualized using a chemiluminescence west-
ern blotting system according to the manufacturers’ in-
structions (Amersham).
Data analysis
Statistical calculations were carried out using GraphPad
Prism 5 Statistical Software Package (GraphPad Software
Inc., La Jolla, CA, USA). The interactive effect of either
METH, cocaine or alcohol user with HIV-positive sub-
jects compared with control subjects were calculated
using analysis of variance and the Student’s t test as well
as the nonparametric Mann–Whitney U test. Signifi-
cance of comparisons between normal subjects and
subjects with either cocaine or alcohol use with HIV-
positive subjects is denoted by P <0.05.
Results
Plasma samples from alcohol, METH, and cocaine users
and HIV-positive subjects alone or HIV-positive with
METH, cocaine and alcohol users were compared with
normal subjects. The normal drug-free groups consisted
of eight subjects and were healthy, normally developing
subjects, unrelated to the diseased patients.
Plasma was analyzed for CRP and SAA by ELISA in
METH, cocaine, and alcohol users and HIV-positive alone
or in drugs of abuse METH, cocaine, and alcohol with
HIV-positive subjects. Figure 1 shows the significantly ele-
vated levels of plasma CRP in HIV-positive with METH,
cocaine and alcohol users compared with just METH, co-
caine and alcohol users, and HIV-positive subjects. Simi-
larly, Figure 2 shows significantly elevated levels of plasma
SAA in HIV-positive with METH, cocaine and alcohol
users compared with just METH, cocaine and alcohol
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users and HIV-positive subjects alone. The plasma CRP
and SAA levels in METH, cocaine and alcohol users and
HIV-positive subjects when compared with normal sub-
jects significantly increased, whereas these effects were
significantly less when compared with combination of
HIV-positive with METH, cocaine and alcohol users.
To validate the increased levels by ELISA, we also inves-
tigated plasma levels of CRP and SAA protein by western
blot analysis in randomly selected plasma samples from
normal subjects, METH, cocaine, and alcohol users, HIV-
positive subjects alone and cocaine, METH and alcohol
users with HIV-positive subjects. The protein expression
of CRP and SAA is represented in Figures 3 and 4 respect-
ively in HIV-positive subjects with METH abuse, HIV-
positive subjects with cocaine abuse and HIV-positive
subjects with alcohol use compared with controls. Figures 3
and 4D,E,F represent densitometric evaluations of the sta-
tistically significant difference respectively in METH, co-
caine and alcohol users with HIV-infected subjects. A
concordance was observed between the elevated levels of
CRP and SAA by ELISA and western blotting analysis. The
observed results of acute phase proteins CRP and SAA in-
versely correlated with CD4 counts and were significantly
reduced in METH, cocaine, and alcohol users with HIV-
Figure 1 Plasma levels of C-reactive protein estimated in HIV-positive drug users. Plasma levels of C-reactive protein (CRP) estimated by
ELISA in (A) methamphetamine (METH), (B) cocaine and (C) alcohol users with HIV-positive. Horizontal lines indicate the mean ± standard error of
the mean.
Figure 2 Plasma levels of serum amyloid A protein estimated in HIV-positive drug users. Plasma levels of serum amyloid A (SAA) protein
estimated by ELISA in (A) methamphetamine (METH), (B) cocaine and (C) alcohol users with HIV-positive. Horizontal lines indicate mean ±
standard error of the mean.
Samikkannu et al. Journal of Neuroinflammation 2013, 10:113 Page 3 of 7
http://www.jneuroinflammation.com/content/10/1/113
Figure 3 Plasma C-reactive protein expression in HIV-positive drug users. Plasma C-reactive protein (CRP) expression elucidated by western
blots in (A) HIV-positive methamphetamine (METH) users, (B) HIV-positive cocaine users and (C) HIV-positive alcohol users compared with age-
matched normal subjects. (D), (E), (F) Represented percentage densitometric values of CRP protein levels (% control). Data expressed as mean ±
standard error of the mean of randomly selected in each groups for three subjects.
Figure 4 Plasma serum amyloid A protein expression in HIV-positive drug users. Plasma serum amyloid A (SAA) protein expression
elucidated by western blots in (A) HIV-positive methamphetamine (METH) users, (B) HIV-positive cocaine users and (C) HIV-positive alcohol users
compared with age-matched normal subjects. (D), (E), (F) Represented percentage densitometric values of SAA protein levels (% control). Data
expressed as mean ± standard error of the mean of randomly selected in each groups for three subjects.
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infected subjects compared with HIV-infected subjects
(Table 1).
Discussion
Studies have reported that HIV infections are enhanced
by METH, cocaine and alcohol use in vitro and in vivo
[21,25,26]. Population and clinical studies have demon-
strated that illicit drugs interact with HIV-positive subjects
and accelerate viral replication and disease progression
synergistically, by impairing immune and neuronal func-
tions [18,27,28]. We measured acute phase proteins CRP
and SAA in plasma from METH, cocaine and alcohol
users alone or from HIV-positive subjects with drugs of
abuse cocaine, METH and alcohol subjects using the
ELISA method. The expressions of both acute phase pro-
tein CRP and SAA levels were significantly elevated when
compared with age-matched control groups. Furthermore,
there was a significant association between CRP and SAA
levels in METH, cocaine and alcohol users with HIV in-
fection associated with reduced CD4 counts (Table 1).
The plasma levels of acute phase proteins were positively
correlated with METH, cocaine and alcohol users alone
and HIV-positive subjects, providing additional evidence
for increased disease progression and immune susceptibil-
ity level of inflammatory markers CRP and SAA.
Studies have shown that CRP and SAA level are ele-
vated in cocaine abusers, alcohol users and cigarette
smokers [19,20,29]. The inflammatory markers CRP and
SAA proteins play a major role in chronic inflammation
of HIV infection, inducing immune dysfunction, disease
progression and subsequently decreased CD4 count [22].
Recent work demonstrated that the level of inflamma-
tory marker CRP was elevated in patients with intracere-
bral hemorrhage in alcohol users [30]. Cocaine abusers
had fivefold to sixfold increases in the levels of CRP, which
lead to sudden heart attack and may also trigger fatal car-
diovascular events such as strokes [19]. In addition,
chronic inflammatory changes that occur during stress
and depression subsequently lead to dementia. CRP plays
a wide role in the development of cardiovascular compli-
cations, dementia, cognitive impairments and Alzheimer’s
disease. Recent studies report that HIV-positive patients
showed increased levels of CRP compared with the
HIV-negative population [22], although CRP and SAA
levels in METH, cocaine and alcohol users were not
compared with HIV-infected subjects. Previous research
has reported that the inflammatory acute phase proteins
CRP and SAA were increased in cocaine and alcohol users
[19,20]. These studies are consistent and suggest that at
least part of the immunopathogenic mechanisms related
to METH, cocaine and alcohol users may be due to a per-
sistent state of subclinical inflammation. We observed that
an elevated expression of CRP and SAA in METH, co-
caine and alcohol subjects is associated with the HIV-
positive subjects. Cocaine, and alcohol are frequently used
together [31] and this combination is associated with en-
hanced immune and central nervous system toxicity and
dependence severity [32]. These results suggest that the
levels of acute phase proteins CRP and SAA may serve as
biomarkers of illicit drug users and HIV-infected subjects.
These inflammatory proteins CRP and SAA are the
most dramatic acute phase reactants, and are associated
with high-density lipoproteins. Normally SAA levels are
present at <5 μg/ml in plasma; however, during activa-
tion the protein levels increase more than 500-fold by
acute phase and subsequently lead to psychomotor dys-
function. However, studies have reported that the apolipo-
protein E4 allele has been a major player in dementia and
peripheral neuropathy [33]. Also, studies have shown con-
troversial reports in apolipoprotein E4 dependence and in-
dependence in HIV-associated dementia [33,34]. This
specific allele of the apolipoprotein E4 region has been as-
sociated with increasing oxidative stress and is very
sensitive in HIV-associated dementia patients. How-
ever, studies have supported that CRP acts as an indi-
cator of bacterial and viral infection and it is linked
with the apolipoprotein E4 allele. The higher level of
CRP associated with apolipoprotein E4 has been reported
to exacerbate the susceptibility of dementia and cognitive
impairments [35]. Studies have reported that reduced
plasma tryptophan increased neuronal dysfunction includ-
ing behavioral and cardiovascular impairments [36,37].
However, HIV infection and disease progression are ma-
jorly activated by tryptophan catabolism in HIV-infected
subjects, illicit drug use, as well as alcohol users [38,39],
and further tryptophan deficiencies targeting CD4 cells.
The altered tryptophan catabolism changes to acidic pH
in blood plasma, resulting in negative charge in CRP [40].
Table 1 Baseline characteristics of HIV-positive subjects with methamphetamine, cocaine and alcohol users
Normal
subjects
HIV-positive
subjects
HIV-positive
Methamphetamine
users
Cocaine users Alcohol users
Age 39.23 ± 2.32 48.38 ± 1.75 45.27 ± 2.08 47.75 ± 1.30 43.75 ± 2.63
Sex Male 6 Male 5 Male 6 Male 5 Male 6
Female 2 Female 3 Female 2 Female 3 Female 2
CD4 cell – ≥406/μl ≥186/μl ≥214/μl ≥237/μl
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This result suggests that acute phase proteins lead trypto-
phan deficiencies in drugs of abuse and HIV-infected sub-
jects and may play an interactive role with acceleration of
viral replication and disease progression.
Conclusions
In this study we examined the interactive role of illicit
drugs in HIV-positive subject’s plasma proteins CRP and
SAA in order to understand their role in HIV pathogen-
esis. Our results clearly indicate that drugs of abuse such
as METH, cocaine and alcohol are capable of accelerat-
ing the secretion of CRP and SAA levels and subse-
quently decrease the CD4 cell count, which causes
chronic inflammatory effects. These observations lead to
the hypothesis that acute phase proteins CRP and SAA
play a major role and contribute to viral replication and
disease progression in drug abusers.
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